Except for CBR antagonists and inhibitors of enzymes responsible for eCB degradation, all compounds possess proven vasodilatory properties, in many cases also in hypertension (Table 2 and Section 7), and were shown to decrease BP more strongly in anesthetized hypertensive rats than normotensive rats after acute i.v. administration (Section 8). Here, CNR1 is linked to Hypertension.